ConsiGma® Continuous Processing

Product description

Continuous processing technologies have the potential to transform the future of pharmaceutical development and manufacturing, and deliver customized quantities of drugs to patients in need in a quick and efficient way. GEA’s ConsiGma® is a multipurpose platform that has been designed to transfer powder into coated tablets in development, pilot, clinical and production volumes in a single compact unit. The system can perform dosing and mixing of raw materials, wet or dry granulation, drying, tableting and quality control, all in one line.

Specifications

Sales markets	Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

More products from GEA Group

Tomorrow’s Pharmaceutical Processing Solutions Today

GEA’s comprehensive portfolio of standard and custom-designed equipment, machinery and entire production lines includes benchtop R&D solutions, completely integrated industrial-scale plant and both batch-based and continuous processing technology.

Solid dosage: From powder handling to granul...

More info

Liquid Pharmaceutical & Biotechnology Expertise

Drug production and the manufacture of active pharmaceutical ingredients (APIs) demands the very highest product quality and purity standards, as well as validated manufacturing processes. As a supplier of sterile process plant with many years of experience, GEA can draw upon the comprehensive theoretical ...

More info

ConsiGma® Continuous Processing